Advertisement
Advertisement
TLRY
Tilray Brands, Inc. Common Stock
5.32
USDSponsored
-0.18
-3.27%
May 15, 15:59 UTC -4
Closed
After-Market
5.32
0.00
-0.09%
TLRY Earnings Reports
Positive Surprise Ratio
TLRY beat 5 of 20 last estimates.
25%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q4 26 (Revenue/ EPS)
$251.13M
/$0.00
Implied change from Q3 26 (Revenue/ EPS)
+21.48%
/-100.00%
Implied change from Q4 25 (Revenue/ EPS)
+11.84%
/-100.00%
Tilray Brands, Inc. Common Stock earnings per share and revenue
On Apr 01, 2026, TLRY reported earnings of -0.24 USD per share (EPS) for Q3 26, missing the estimate of -0.14 USD, resulting in a -68.07% surprise. Revenue reached 206.73 million, compared to an expected 205.38 million, with a 0.66% difference. The market reacted with a -5.10% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 7 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 251.13 million USD, implying an decrease of -100.00% EPS, and increase of 21.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.18
Surprise
-154.60%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
Cytosorbents Corp.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.08
Surprise
-42.60%
Bonk, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.23
Surprise
-
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
FAQ
What were Tilray Brands, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Tilray Brands, Inc. Common Stock reported EPS of -$0.24, missing estimates by -68.07%, and revenue of $206.73M, 0.66% above expectations.
How did the market react to Tilray Brands, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -5.1%, changed from $6.47 before the earnings release to $6.14 the day after.
When is Tilray Brands, Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for Tilray Brands, Inc. Common Stock's next earnings report?
Based on 7
analysts, Tilray Brands, Inc. Common Stock is expected to report EPS of -- and revenue of $251.13M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement